Resel Pereira

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Xiaoyong Fu, Rinath Jeselsohn, Resel Pereira et al. · Proceedings of the National Academy of Sciences · 2016 · 184 citations · Full text

Medicine, Molecular Biology, Oncology +17

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 171 citations · Full text

Medicine, Genetics, Oncology +17

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

Vidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis et al. · Molecular Cancer Research · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner

Mohamed Reda Fazazi, Prenitha Mercy Ignatius Arokia Doss, Resel Pereira et al. · Nature Communications · 2024 · 20 citations · Full text

Life Sciences, Immunology, Neurology +17